fisetin (10-50 Î¼m) strongly inhibited the regular serum plus growth supplement- and vascular endothelial growth factor (vegf)-induced growth (up to 92%, p < 0.001) and survival (up to 16%, p < 0.001) of huvec in a dose- and time-dependent manner.